4.8 Article

Enhanced dual contrast agent, Co2+-doped NaYF4:Yb3+,Tm3+ nanorods, for near infrared-to-near infrared upconversion luminescence and magnetic resonance imaging

Journal

BIOMATERIALS
Volume 35, Issue 33, Pages 9167-9176

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2014.07.031

Keywords

Upconversion luminescence; Nanorod; Magnetic resonance imaging; Multi-modality imaging; Rare earth nanomaterials; Lanthanide nanoparticle

Funding

  1. Natural Science Foundation of China [21371100, 31170477, 51272100, 51273073]
  2. Priority Academic Program Development of Jiangsu Higher Education Institutions, Natural Science Foundation of Jiangsu Province [BK2013139]
  3. Jiangsu Planned Projects for Postdoctoral Research Funds [1201047C]

Ask authors/readers for more resources

Dual-modality imaging with magnetic resonance (MR) and upconversion luminescence (UCL) is a promising technique for molecular imaging in biomedical research. Multifunctional lanthanide-based nanoparticles have been widely investigated as agents for contrast enhanced MR and fluorescence imaging. However, the use of rare earth fluoride nanoparticles for dual-modality imaging of T2-weighted MR and UCL is rarely reported. We find that NaYF4:Yb3+,Tm3+,Co2+' (MUC) nanorods can be applied as a high-performance dual contrast agent for both T2-weighted MR and UCL dual-modality imaging. After modification with 6-O-carboxymethyl chitosan (OCC), MUC nanorods can be endocytosed by cells without showing signs of cytotoxicity. High-quality UCL images of living cells incubated with MUC-OCC nanorods were acquired on a near-infrared (NIR) confocal microscopy under the excitation at 980 nm. Moreover, MUC-OCC nanorods display high transverse (r2) relaxivities in vitro. The application of low-dose MUC-OCC nanorods for NIR-to-NIR UCL and MR dual-modality in vivo imaging was also carried out successfully. In addition, the toxicity of MUC-OCC nanorods was evaluated by MTT assay, serological tests and histological analysis of visceral organs. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available